PM54-A-003-25 - A Multcenter Open-label Phase 1/2 Safety Run In and Expansion Study of PM54 in Combination with Immunotherapy (PM54-A-003-25)

Principal Investigator

Prof Mark Middleton

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1013898